Clinical trial

68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI

NCT07209878

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2020-01-10

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2020-01-10Date precision: day

Registry last updated2025-10-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancer (Adenocarcinoma)unresolved

Interventions

68Ga-PSMA-11DRUG

Sponsors & collaborators

First Affiliated Hospital of Fujian Medical Universitylead sponsor

Mapped research locations

FuzhouFujian, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07209878 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.